Please view our cookie policy that explains what cookies are and how they are used on our website. This also provides you with a guide on how to disable cookies, but please be aware that parts of the site will not function correctly if you disable them.

By closing this message, you consent to our use of cookies on this device in accordance with our cookie policy unless you have disabled them.

North Cumbria University Hospitals NHS Trust - 70 years of the NHS

Home > Our services > Rhidian Shelton

Rhidian Shelton

Speciality

Cardiology

Based at

The Cumberland Infirmary and West Cumberland Hospital
Secretary contact - 01228 814384

Year qualified

1998

Professional qualifications

MD (Doctor of Medicine); MRCP (Member of the Royal College of Physicians); MBChB (Bachelor of Medicine Bachelor of Surgery).

Treatment and procedures

Percutaneous Coronary Intervention (angioplasty)

Clinical Interests / specialist areas

Acute Coronary Syndromes, Myocardial Revascularisation, Coronary physiology.

Professional membership

British Cardiovascular Interventions Society.

Research

 

Awards

 

Publications

1.  Shelton RJ, et al. Bivalirudin in patients undergoing primary percutaneous coronary intervention for acute ST-elevation myocardial infarction: outcomes in a large real-world population. 2011

2. Shelton RJ, et al. 3 year clinical outcome with the EndeavorTM Zotarolimus Eluting Stent in Primary Percutaneous Coronary Intervention for ST Elevation Myocardial Infarction: The Endeavor Primary PCI Study (E-PPCI). Journal of Interventional Cardiology 2011

3. Shelton RJ, Blackman DJ. Management of Acute ST Elevation Myocardial Infarction. Medicine Journal, 2010 Aug; 38(8): 431-43

4. Shelton RJ, et al. Real-world Outcome from ST-Elevation Myocardial Infarction in the Very Elderly Before and After the Introduction of a 24/7 Primary Percutaneous Coronary Intervention Service. American Heart Journal, 2010 Jun; 159(6):956-63.

5. Shelton RJ, et al. Cardiac output does not limit submaximal exercise capacity in patients with chronic heart failure. Eur J Heart Fail. 2010 Sep;12(9): 983-9

6. Shelton RJ, Clark AL Kaye GC, Cleland JF. The Atrial fibrillation paradox of heart failure. Congestive Heart Failure Journal. 2010 Jan-Feb;16(1): 3-9  

7. Shelton RJ, Blackman DJ. What would be the ideal drug-eluting stent for the management of long lesions? Interventional Cardiology, 2009; 4 :44-47

8.  Shelton RJ, et al. A comparison between monophasic and biphasic defibrillation for the cardioversion of persistent atrial fibrillation in patients with and without heart failure. Int J Cardiol. 2009 Oct 25 Epub.

9. Shelton RJ, et al. A Randomised, Controlled Study of Rate versus Rhythm Control in patients with Chronic Atrial Fibrillation and Heart Failure: (CAFÉ-II). Heart 2009 Jun; 95(11):924-30. Highlighted in Nature cardiovascular reviews July 2009.

10. Shelton RJ, et al. Natriuretic peptides in patients with atrial fibrillation and advanced chronic heart failure: determinants and prognostic value of (NT-) ANP and (NT-pro) BNP. Europace. 2007 Feb;9(2):147

11. Cleland JGF, Shelton RJ, Nikitin N, Ford S, Frison L, Grind M. Prevalence of markers of heart failure in patients with atrial fibrillation and the effects of ximelagatran compared to warfarin on the incidence of morbid and fatal events: a report from the SPORTIF III and V trials. Eur J Heart Fail. 2007;9(6-7):730-9

12. Shelton RJ, et al. The diagnostic utility of N-terminal pro-B-type natriuretic peptide for the detection of major structural heart disease in patients with atrial fibrillation. Eur Heart J. 2006 Oct;27(19):2353-61.

13. Shelton RJ, et al. Effect of a community heart failure clinic on uptake of beta blockers by patients with obstructive airways disease and heart failure. Heart. 2006 Mar;92(3):331-6.

14. Shelton RJ, Allinson A, Johnson J, Smales C, Kaye GC: Four years experience of a nurse-led elective cardioversion service within a district general hospital setting. Europace. 2006 Jan;8(1):81-5.

15. Ingle L, Shelton RJ, Cleland JGF, Clark AL. The reproducibility and sensitivity of the six-minute walk test in patients with chronic heart failure: European Heart Journal, 2005 Sep; 26(17):1742-51. Epub 2005 Apr 14.

16. Ingle L, Shelton RJ, Cleland JGF, Clark AL. Poor relationship between exercise capacity and spirometric measurements in patients with more symptomatic heart failure. J Card Fail. 2005 Oct;11(8):619-23.

17. Shelton RJ, et al. Clinical trials update from the American Heart Association meeting: ACORN-CSD, primary care trial of chronic disease management, PEACE, CREATE, SHIELD, A-HeFT, GEMINI, vitamin E meta-analysis, ESCAPE, CARP, and SCD-HeFT cost-effectiveness study. European Journal of Heart Failure 2005; 7: 127-135.

18. Shelton RJ. Prevention of Atrial Fibrillation after Cardioversion: Results of the PAFAC trial. European Heart Journal. 2004; 25(23): 2174-75

19. Shelton RJ. The AFFIRM Study: Approaches to control rate in Atrial Fibrillation. Journal of American College of Cardiology. 2004; 44(12): 2418-19.

20. Shelton RJ, Kaye GC, Cleland JG. Controlling persistent atrial fibrillation. Quarterly Journal of Medicine 2004; 97(3):179-80.

21. Rajeswaran C, Shelton RJ, Gilbey SG. Management of amiodarone-induced thyrotoxicosis. Swiss Medical Weekly 2003; 133(43-44):579-85.

22. Cleland JG, Freemantle N, Kaye GC, Shelton RJ et al. Clinical trials update from the American Heart Association meeting: Omega-3 fatty acids and arrhythmia risk in patients with an implantable defibrillator, ACTIV in CHF, VALIANT, the Hanover autologous bone marrow transplantation study, SPORTIF V, ORBIT and PAD and DEFINITE. European Journal of Heart Failure 2004; 6(1):109-15.

23. Hardern R, Taylor A, Shelton R, Russell A. Developing a rapid diagnosis and treatment centre: estimating impact on hospital resources. Emergency Medical Journal 2004; 21(2):165-9.

British Cardiovascular Society Editorials:

1. Shelton RJ. TAVI - 'Mind your Head'. British Cardiovascular Society.

Editorial. Published online February 2011

http://www.bcs.com/pages/news_full.asp?NewsID=19791965

2. Shelton RJ. Primary multi-vessel PCI. British Cardiovascular Society,

Editorial. Published online June 2010

http://www.bcs.com/pages/news_full.asp?NewsID=19791896

3. Shelton RJ. Primary PCI: More may not be better. British Cardiovascular Society Editorial, Published online Jan 2010

http://www.bcs.com/pages/news_full.asp?NewsID=19549169

4. Shelton RJ. Bleeding Angioplasty. British Cardiovascular Society Editorial, Published online May 2009

http://www.bcs.com/pages/news_full.asp?NewsID=19356771

5. Shelton RJ. Drug eluting stents reduce restenosis and recurrent ischaemia in Acute STEMI. British Cardiovascular Society Editorial, Published online May 2009.

http://www.bcs.com/pages/news_full.asp?NewsID=19176141

6. Shelton RJ. Occluded infarct arteries: open them at the time of infarct or not at all. British Cardiovascular Society Editorial, Published online Jan 2009,

http://www.bcs.com/pages/news_full.asp?NewsID=19021989

7. Shelton RJ. Clopidogrel resistance predicts 1 year ACS outcome.

British Cardiovascular Society Editorial, Published online Jan 2009,

http://www.bcs.com/pages/news_full.asp?NewsID=19012513

8. Shelton RJ. BBC ONE: A simple answer to a complex question?

British Cardiovascular Society Editorial, Published online Oct 2008,

http://www.bcs.com/pages/news_full.asp?NewsID=18831538

9. Shelton RJ. FAME puts the ‘oculo-stenotic reflex’ under pressure.

British Cardiovascular Society Editorial, Published online Oct 2008,

http://www.bcs.com/pages/news_full.asp?NewsID=18831539

10. Shelton RJ. Is it time to say ‘ciao’ to anticoagulation in elective PCI?

British Cardiovascular Society Editorial, Published online Oct 2008,

http://www.bcs.com/pages/news_full.asp?NewsID=18831540

 

Abstracts:

1. Blackman DJ, MacCarthy P, Shelton RJ, Thomas, M, Moat N, DeBelder M, Ludman P, Wendler O, Cunningham D, Gray H. Outcome of Transcatheter Aortic Valve Implantation by valve type and access route. UK TAVI Investigators. PCR London Valves 2011.

2.  Shelton RJ, Y Shamout, O Elkhateeb, M Love, H Beydoun. One year clinical outcomes following left main stem percutaneous coronary intervention. Atlantic Canada Cardiovascular Conference, 2011.

3. Eftychiou C, Shelton RJ, Somers K, Liu A, Burton-Wood N, Anderson M, Makri L, Blaxill JM, McLenachan JM, Wheatcroft SB, Greenwood JP, Blackman DJ. Bivalirudin in patients undergoing primary percutaneous coronary intervention for acute ST-elevation myocardial infarction: outcomes in a large real-word population. EuroPCR Coference, Paris, 2011.

4. Shelton RJ, McLenachan JM, Wheatcroft SB, Blackman DJ, Greenwood JP. Incidence of Tako-Tsubo Cardiomyopathy In Patients Undergoing Primary Angioplasty For ST Elevation Myocardial Infarction. British Cardiovascular Society Annual Scientific Conference, Manchester, 2008.

5.  Shelton RJ, Goode K, Cleland JGF, Clark AL The utility of N-terminal pro-B-type natriuretic peptide for the detection of major structural heart disease in patients with atrial fibrillation. American Heart Association Scientific Conference, Dallas, 2005.

6.  Shelton RJ, Rigby AS, Goode K, Cleland JGF, Clark AL. Utility of N-terminal pro-B-type natriuretic peptide for predicting systolic dysfunction in patients with and without atrial fibrillation. European Society of Cardiology Congress Meeting, Stockholm, 2005.

7. Shelton RJ, Allinson A, Johnson T, Smales C, Kaye GC. Four years experience of an elective external cardioversion service. EuroPACE Annual Scientific Conference, Prague 2005.

8. Shelton RJ, Clark AL, Cleland JGF. The prevalence/incidence paradox of atrial fibrillation in heart failure. British Cardiac Society Annual Conference, Manchester 2005.

9. Ingle L, Shelton RJ, Rigby AS, Cleland JGF, Clark AL. Reduced contribution of spirometric abnormalities to exercise capacity in patients with more symptomatic heart failure. Circulation 2004; 110 (17, supp III): 534. Moderated poster presented by RJ Shelton at the American Heart Association Scientific Conference, New Orleans, 2004.

10. Shelton RJ, Allinson A, Johnson T, Smales C, Kaye GC. Nurse-led elective external cardioversion service within a district general hospital setting. British Cardiac Society Annual Conference, Manchester, 2005.

11.  Hardern R, Taylor A, Shelton RJ, Russell A. Developing a rapid diagnosis and treatment centre: estimating impact on hospital resources. Presented at British Association for Accident and Emergency Medicine Conference, 2002